Women's Lung Cancer Surpasses Breast Cancer as Deadliest Cancer Type, According to Recent Findings on Relative Mortality (RLP)
In an effort to combat the growing issue of lung cancer, particularly among women, plans are underway to introduce a nationwide screening program in spring 2026. This initiative will be funded by statutory health insurance companies, targeting individuals who smoke or have smoked in the past.
Smoking remains the primary and well-established risk factor for lung cancer, with the increasing rate of the disease among women clearly linked to cigarette smoking. However, the use of e-cigarettes, vapes, shishas, and tobacco heaters is on the rise, especially among young people and young adults. While evidence suggests a potential association between these products and lung cancer risk, more rigorous research is needed to confirm these associations.
Vaping, for instance, releases nicotine and other chemicals that can adversely affect respiratory health and may exacerbate lung injury. However, it generally produces fewer carcinogens and no tar compared to smoking cigarettes. Lung specialist Kreuter, an advocate for prevention and political measures, has criticized dual use (simultaneous use of vapes and conventional cigarettes).
Early detection through low-dose computed tomography (LDCT) scans is critical in reducing the impact of lung cancer. Such programs, like Wellstar's lung cancer screening initiative, have demonstrated success in detecting early-stage lung cancer before symptoms arise, allowing for more effective treatment and improved survival outcomes. LDCT screening is especially valuable for individuals at high risk, such as current or former smokers, and its wider application could help mitigate the rising burden of lung cancer.
Rhineland-Palatinate, with several lung cancer centers and an increasingly better networking of general practitioners, specialist practices, and radiology centers, is well-positioned to implement this screening program. Lung specialist Kreuter welcomes the planned screening, stating it's a huge step in the right direction.
In conclusion, smoking remains the main driver of rising lung cancer rates in women. E-cigarettes and vapes may increase lung cancer risk, but current evidence is suggestive, not definitive. Vaping is less harmful than smoking but still carries respiratory and possible carcinogenic risks. Early detection through LDCT enables earlier diagnosis and better prognosis in lung cancer, reducing its overall health impact. This integrated approach underscores the need for continued public health efforts targeting smoking cessation, cautious evaluation of vaping risks, and broad implementation of lung cancer screening in at-risk populations.
Science shows that smoking is the primary risk factor for lung cancer, a growing issue among women. Medical-conditions like lung cancer are associated with the use of e-cigarettes, vapes, shishas, and tobacco heaters, particularly among young people. Health-and-wellness initiatives, such as the proposed nationwide screening program in 2026, aim to combat lung cancer by early detection through low-dose computed tomography (LDCT) scans, which are especially valuable for current or former smokers. Women's health is significantly affected by lung cancer, making such screening programs crucial in reducing its impact.
){kind=link}